skip to main content
Guest
My Research
My Account
Sign out
Sign in
This feature requires javascript
Library Search
Find Databases
Browse Search
E-Journals A-Z
E-Books A-Z
Citation Linker
Help
Language:
English
Vietnamese
This feature required javascript
This feature requires javascript
Primo Search
All Library Resources
All
Course Materials
Course Materials
Search For:
Clear Search Box
Search in:
All Library Resources
Or hit Enter to replace search target
Or select another collection:
Search in:
All Library Resources
Search in:
Print Resources
Search in:
Digital Resources
Search in:
Online E-Resources
Advanced Search
Browse Search
This feature requires javascript
Search Limited to:
Search Limited to:
Resource type
criteria input
All items
Books
Articles
Images
Audio Visual
Maps
Graduate theses
Show Results with:
criteria input
that contain my query words
with my exact phrase
starts with
Show Results with:
Search type Index
criteria input
anywhere in the record
in the title
as author/creator
in subject
Full Text
ISBN
ISSN
TOC
Keyword
Field
Show Results with:
in the title
Show Results with:
anywhere in the record
in the title
as author/creator
in subject
Full Text
ISBN
ISSN
TOC
Keyword
Field
This feature requires javascript
Venous thromboembolism in women: a specific reproductive health risk
Human reproduction update, 2013-09, Vol.19 (5), p.471-482
[Peer Reviewed Journal]
ISSN: 1355-4786 ;EISSN: 1460-2369 ;DOI: 10.1093/humupd/dmt028 ;PMID: 23825156
Full text available
Citations
Cited by
View Online
Details
Recommendations
Reviews
Times Cited
External Links
This feature requires javascript
Actions
Add to My Research
Remove from My Research
E-mail
Print
Permalink
Citation
EasyBib
EndNote
RefWorks
Delicious
Export RIS
Export BibTeX
This feature requires javascript
Title:
Venous thromboembolism in women: a specific reproductive health risk
Author:
Eichinger, S.
;
Evers, J.L.H.
;
Glasier, A.
;
La Vecchia, C.
;
Martinelli, I.
;
Skouby, S.
;
Somigliana, E.
;
Baird, D.T.
;
Benagiano, G.
;
Crosignani, P.G.
;
Gianaroli, L.
;
Negri, E.
;
Volpe, A.
Subjects:
Adult
;
Age Factors
;
Aged
;
Aged, 80 and over
;
Contraception - adverse effects
;
Contraceptives, Oral, Hormonal - adverse effects
;
Contraceptives, Oral, Hormonal - therapeutic use
;
Female
;
Hormone Replacement Therapy - adverse effects
;
Humans
;
Incidence
;
Infertility, Female - drug therapy
;
Male
;
Middle Aged
;
Ovulation Induction - adverse effects
;
Pregnancy
;
Pregnancy Complications, Cardiovascular - chemically induced
;
Pregnancy Complications, Cardiovascular - epidemiology
;
Pregnancy Complications, Cardiovascular - prevention & control
;
Pulmonary Embolism - etiology
;
Reproductive Health
;
Risk Factors
;
Sex Factors
;
Thrombophilia - chemically induced
;
Thrombophilia - epidemiology
;
Venous Thromboembolism - chemically induced
;
Venous Thromboembolism - epidemiology
;
Venous Thromboembolism - prevention & control
;
Young Adult
Is Part Of:
Human reproduction update, 2013-09, Vol.19 (5), p.471-482
Description:
BACKGROUND Venous thromboembolism (VTE) is a specific reproductive health risk for women. METHODS Searches were performed in Medline and other databases. The selection criteria were high-quality studies and studies relevant to clinical reproductive medicine. Summaries were presented and discussed by the European Society of Human Reproduction and Embryology Workshop Group. RESULTS VTE is a multifactorial disease with a baseline annual incidence around 50 per 100 000 at 25 years and 120 per 100 000 at age 50. Its major complication is pulmonary embolism, causing death in 1-2% of patients. Higher VTE risk is associated with an inherited thrombophilia in men and women. Changes in the coagulation system and in the risk of clinical VTE in women also occur during pregnancy, with the use of reproductive hormones and as a consequence of ovarian stimulation when hyperstimulation syndrome and conception occur together. In pregnancy, the risk of VTE is increased ~5-fold, while the use of combined hormonal contraception (CHC) doubles the risk and this relative risk is higher with the more recent pills containing desogestrel, gestodene and drospirenone when compared with those with levonorgestrel. Similarly, hormone replacement therapy (HRT) increases the VTE risk 2- to 4-fold. There is a synergistic effect between thrombophilia and the various reproductive risks. Prevention of VTE during pregnancy should be offered to women with specific risk factors. In women who are at high risk, CHC and HRT should be avoided. CONCLUSIONS Clinicians managing pregnancy or treating women for infertility or prescribing CHC and HRT should be aware of the increased risks of VTE and the need to take a careful medical history to identify additional co-existing risks, and should be able to diagnose VTE and know how to approach its prevention.
Publisher:
England
Language:
English
Identifier:
ISSN: 1355-4786
EISSN: 1460-2369
DOI: 10.1093/humupd/dmt028
PMID: 23825156
Source:
Geneva Foundation Free Medical Journals at publisher websites
MEDLINE
Alma/SFX Local Collection
This feature requires javascript
This feature requires javascript
Back to results list
This feature requires javascript
This feature requires javascript
Searching Remote Databases, Please Wait
Searching for
in
scope:(TDTS),scope:(SFX),scope:(TDT),scope:(SEN),primo_central_multiple_fe
Show me what you have so far
This feature requires javascript
This feature requires javascript